Taar1 has been the preferential target of these investigations, because of its potential role in the pathogenesis of mental and metabolic disorders, which has been extensively reviewed elsewhere (Rutigliano et al. 2017; Gainetdinov et al. 2018; Schwartz et al. 2018). The gene discussed is TAAR1; the disease is metabolic disease.